Tool Review

SparkRx

Digital therapeutic for teen and young adult depression

Support Level
Self-Help
Pricing
Enterprise
Platforms
Web
Privacy
Not rated

Best For

  • Child psychiatrists
  • adolescent psychologists
  • and school-based mental health providers treating teens and young adults ages 13-22 with depression symptoms

Not Recommended For

  • Patients with severe depression requiring hospitalization or those outside the 13-22 age range
Reviewed by HeyPsych Board· Last reviewed September 2026

About SparkRx

SparkRx is the first digital therapeutic designed specifically for adolescents and young adults ages 13-22 with symptoms of depression. Developed by Limbix (acquired by Big Health in 2023), the app delivers a multi-week program based on cognitive behavioral therapy (CBT) and behavioral activation protocols. The self-guided treatment teaches skills including mood tracking, behavioral activation, problem solving, and mindfulness, designed to complement treatment by a clinician. Clinical trials demonstrated a 21% remission rate compared to 4% for control groups, with treatment response rates of 29% versus 16%. Big Health acquired Limbix to expand their evidence-based digital therapeutics into adolescent mental health.

Get SparkRx

Privacy & Security

Privacy Grade
Not rated
HIPAA Compliant
No
Data Sold
No

FAQ

About SparkRx

SparkRx is a digital therapeutic designed for adolescents and young adults ages 13-22 with symptoms of depression, delivering self-guided CBT and behavioral activation through a mobile app.